These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 34058073)

  • 1. Pharmacists as facilitators of pharmacogenomic guidance for antidepressant drug selection and dosing.
    Bishop JR
    Clin Transl Sci; 2021 Jul; 14(4):1206-1209. PubMed ID: 34058073
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacogenomics guided versus standard antidepressant treatment in a community pharmacy setting: A randomized controlled trial.
    Papastergiou J; Quilty LC; Li W; Thiruchselvam T; Jain E; Gove P; Mandlsohn L; van den Bemt B; Pojskic N
    Clin Transl Sci; 2021 Jul; 14(4):1359-1368. PubMed ID: 33641259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacogenomic testing and antidepressant response: problems and promises.
    Smith TL; Nemeroff CB
    Braz J Psychiatry; 2020 Apr; 42(2):116-117. PubMed ID: 32187320
    [No Abstract]   [Full Text] [Related]  

  • 4. A Call for Clear and Consistent Communications Regarding the Role of Pharmacogenetics in Antidepressant Pharmacotherapy.
    Hicks JK; Bishop JR; Gammal RS; Sangkuhl K; Bousman CA; Leeder JS; Llerena A; Mueller DJ; Ramsey LB; Scott SA; Skaar TC; Caudle KE; Klein TE; Gaedigk A
    Clin Pharmacol Ther; 2020 Jan; 107(1):50-52. PubMed ID: 31664715
    [No Abstract]   [Full Text] [Related]  

  • 5. Is there a role for antidepressant and antipsychotic pharmacogenetics in clinical practice in 2014?
    Mulsant BH
    Can J Psychiatry; 2014 Feb; 59(2):59-61. PubMed ID: 24881124
    [No Abstract]   [Full Text] [Related]  

  • 6. Does obtaining CYP2D6 and CYP2C19 pharmacogenetic testing predict antidepressant response or adverse drug reactions?
    Solomon HV; Cates KW; Li KJ
    Psychiatry Res; 2019 Jan; 271():604-613. PubMed ID: 30554109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is Pharmacogenetics Useful in Antidepressant Treatment?
    Fabbri C; Serretti A
    Clin Pharmacol Ther; 2019 Nov; 106(5):916-918. PubMed ID: 31584716
    [No Abstract]   [Full Text] [Related]  

  • 8. Panacea, placebo or poison? Genetically guided treatment for depression.
    Nurmi EL
    Braz J Psychiatry; 2020 Apr; 42(2):118-119. PubMed ID: 32348435
    [No Abstract]   [Full Text] [Related]  

  • 9. [Paraclinical monitoring of antidepressant prescription].
    Sechter D; Vandel S; Bonin B
    Encephale; 1995 Dec; 21 Spec No 4():39-41. PubMed ID: 8808345
    [No Abstract]   [Full Text] [Related]  

  • 10. Improved efficacy with targeted pharmacogenetic-guided treatment of patients with depression and anxiety: A randomized clinical trial demonstrating clinical utility.
    Bradley P; Shiekh M; Mehra V; Vrbicky K; Layle S; Olson MC; Maciel A; Cullors A; Garces JA; Lukowiak AA
    J Psychiatr Res; 2018 Jan; 96():100-107. PubMed ID: 28992526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacogenomic strategy for individualizing antidepressant therapy.
    Lin KM; Perlis RH; Wan YJ
    Dialogues Clin Neurosci; 2008; 10(4):401-8. PubMed ID: 19170397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacogenetics of antidepressant response.
    Porcelli S; Drago A; Fabbri C; Gibiino S; Calati R; Serretti A
    J Psychiatry Neurosci; 2011 Mar; 36(2):87-113. PubMed ID: 21172166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Community pharmacists' educational needs for implementing clinical pharmacogenomic services.
    Berenbrok LA; Hart KM; McGrath SH; Coley KC; Somma McGivney MA; Empey PE
    J Am Pharm Assoc (2003); 2019; 59(4):539-544. PubMed ID: 31010787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improving results with antidepressant drug therapy.
    Sussman N; Cancro R
    Compr Ther; 1990 Feb; 16(2):12-23. PubMed ID: 2311358
    [No Abstract]   [Full Text] [Related]  

  • 15. Integration of machine learning and pharmacogenomic biomarkers for predicting response to antidepressant treatment: can computational intelligence be used to augment clinical assessments?
    Athreya AP; Iyer R; Wang L; Weinshilboum RM; Bobo WV
    Pharmacogenomics; 2019 Sep; 20(14):983-988. PubMed ID: 31559920
    [No Abstract]   [Full Text] [Related]  

  • 16. Efficacy of prospective pharmacogenetic testing in the treatment of major depressive disorder: results of a randomized, double-blind clinical trial.
    Pérez V; Salavert A; Espadaler J; Tuson M; Saiz-Ruiz J; Sáez-Navarro C; Bobes J; Baca-García E; Vieta E; Olivares JM; Rodriguez-Jimenez R; Villagrán JM; Gascón J; Cañete-Crespillo J; Solé M; Saiz PA; Ibáñez Á; de Diego-Adeliño J; ; Menchón JM
    BMC Psychiatry; 2017 Jul; 17(1):250. PubMed ID: 28705252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antidepressant drug interaction considerations.
    Ereshefsky L
    Manag Care; 2001 Aug; 10(8 Suppl):10-3; discussion 18-22. PubMed ID: 11729432
    [No Abstract]   [Full Text] [Related]  

  • 18. Depressed patients' preferences for education about medications by pharmacists in Kuwait.
    Al-Saffar N; Abdulkareem A; Abdulhakeem A; Salah AQ; Heba M
    Patient Educ Couns; 2008 Jul; 72(1):94-101. PubMed ID: 18337052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacist-guided pre-emptive pharmacogenetic testing in antidepressant therapy (PrePGx): study protocol for an open-label, randomized controlled trial.
    Stäuble CK; Lampert ML; Allemann S; Hatzinger M; Hersberger KE; Meyer Zu Schwabedissen HE; Imboden C; Mikoteit T
    Trials; 2021 Dec; 22(1):919. PubMed ID: 34906208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetic and pharmacodynamic significance of antidepressant drug metabolites.
    Caccia S; Garattini S
    Pharmacol Res; 1992 Dec; 26(4):317-29. PubMed ID: 1294938
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.